Abstract
Outcomes with Sequential FLT3-Inhibitor (FLT3i) Based Therapies in Patients (pts) with FLT3-Mutated Acute Myeloid Leukemia (AML) Exposed to Prior FLT3i Based Therapies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have